Literature DB >> 6600289

Membranoproliferative glomerulonephritis and alpha 1-antitrypsin deficiency in children.

C F Strife, G Hug, G Chuck, A J McAdams, C A Davis, J J Kline.   

Abstract

Two white girls had reduced serum concentration of alpha 1-antitrypsin (alpha-AT), phenotype ZZ, and liver disease. Hepatocytes exhibited the microscopic criteria of alpha-AT deficiency. Hypocomplementemia, elevated circulating immune complexes (patient 1), clinical signs of renal disease, and the histologic findings of membranoproliferative glomerulonephritis (MPGN) type I developed. Immunoglobulin A (but not alpha-AT) was demonstrable immunologically as a component of glomerular deposits in patient 1. Among 53 patients with MPGN but without clinical signs of liver disease, none had Pi type Z. Among 23 patients with phenotype ZZ but without clinical signs of kidney disease, six had abnormal complement protein levels, but the pattern did not resemble that of idiopathic MPGN type I. These results are consistent with the conclusion that MPGN in the two patients reported here is a consequence of their chronic liver disease and is not directly related to the presence of the allelic alpha-AT variant PiZ.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600289

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

1.  Orthotopic liver transplantation in liver-based metabolic disorders.

Authors:  A P Mowat
Journal:  Eur J Pediatr       Date:  1992       Impact factor: 3.183

2.  Severe hypertension after liver transplantation in alpha 1 antitrypsin deficiency.

Authors:  G Noble-Jamieson; N D Barnes; S Thiru; A P Mowat
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 3.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

4.  Glomerulonephritis as late manifestation of severe alpha 1-antitrypsin deficiency.

Authors:  R E Stauber; J H Horina; M Trauner; G J Krejs; M Ratschek; M Klimpfinger
Journal:  Clin Investig       Date:  1994-05

Review 5.  Alpha-1-antitrypsin deficiency: current concepts.

Authors:  Alan T Mulgrew; Clifford C Taggart; N Gerry McElvaney
Journal:  Lung       Date:  2007-06-12       Impact factor: 2.584

Review 6.  Alpha 1-antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment.

Authors:  M Hussain; G Mieli-Vergani; A P Mowat
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.